Remote control of magnetic nanocomplexes for delivery and destruction of cancer cells

Orel, Valerii B.; Syvak, L.А.; Орел, В.Е.

doi:10.1177/08853282211005098

Cited by 1 publication

(1 citation statement)

References 90 publications

(94 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The magneto‐mechanochemical synthesis has the advantage of being used to tune MNCs properties via adjusting fixed parameters of CMFs, EMFs and mechanical vibration during drug preparation. Once MNCs have been delivered to the tumor site, they initiate magneto‐mechanochemical effects in response to CMFs and EMFs (V. Orel, Shevchenko, et al, 2015; V. B. Orel, Syvak, & Orel, 2021).…”

Section: Experimental Studies Of Cancer Magnetic Nanotherapymentioning

confidence: 99%

Nanotherapy based on magneto‐mechanochemical modulation of tumor redox state

Orel

Papazoglou

Tsagkaris³

et al. 2022

WIREs Nanomed Nanobiotechnol

Self Cite

View full text Add to dashboard Cite

Magnetic nanoparticles (MNs) are typically used as contrast agents for magnetic resonance imaging or as drug carriers with a remotely controlled delivery to the tumor. However, they can also potentiate the action of anticancer drugs under the influence of applied constant magnetic (CMFs) and electromagnetic fields (EMFs). This review demonstrates the role of magneto‐mechanochemical effects produced by MNs alone and loaded with anticancer agents (MNCs) in response to CMFs and EMFs for modulation of tumor redox state. The combined treatment is suggested to act by two mechanisms: spin‐dependent electron transport propagates free radical chain reactions, while magnetomechanical interactions cause conformational changes in drug molecules loaded onto MNs and generate reactive oxygen species (ROS). By adjusting the parameters of CMFs and EMFs during the magneto‐mechanochemical synthesis and subsequent treatment, it is possible to modulate ROS production and switch redox signaling involved in ERK1/2 and NF‐κB pathways from initiation of tumor growth to inhibition. Observations of tumor volume in different animal models and treatment combinations reported a 6%–70% reduction as compared with conventional drugs. Despite these results, there is a general lack of research in magnetic nanotheranostics that link redox changes across multiple levels of organization in the tumor‐bearing host. Further multidisciplinary studies with more focus on the relationship between the electron transport processes in biomolecules and their effects on the tumor‐host interaction should accelerate the clinical translation of magnetic nanotheranostics. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology

show abstract

Section: Experimental Studies Of Cancer Magnetic Nanotherapymentioning

confidence: 99%